PD-L1 Expression in Clear Cell Renal Cell Carcinoma: An Analysis of Nephrectomy and Sites of Metastases

Background: Expression of programmed death ligand (PD-L1/B7-H1/CD274) represents a mechanism of immune escape for renal cell carcinoma (RCC) cells. Drugs blocking PD-L1 or its receptor are in clinical development and early data suggests that tumor PD-L1 expression may predict response. Patients and...

Descripción completa

Detalles Bibliográficos
Autores principales: Jilaveanu, L.B., Shuch, B., Zito, C. R., Parisi, F., Barr, M., Kluger, Y., Chen, L., Kluger, H. M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2014
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3931264/
https://www.ncbi.nlm.nih.gov/pubmed/24563671
http://dx.doi.org/10.7150/jca.8167

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3931264/
https://www.ncbi.nlm.nih.gov/pubmed/24563671
http://dx.doi.org/10.7150/jca.8167

Ejemplares similares